An elderly patient with advanced lung cancer achieved long-term survival using Chinese medicine: An alternative treatment strategy for cancer patients aged 80 or older without a tissue confirmed diagnosis

Rui Liu; Shu-lin He; Yoshiro Hirasaki; Hong-gang Zheng; Bao-jin Hua

doi:10.1007/s11655-015-2309-9

Your Location：

Home >

Browse articles >

An elderly patient with advanced lung cancer achieved long-term survival using Chinese medicine: An alternative treatment strategy for cancer patients aged 80 or older without a tissue confirmed diagnosis

OriginalPaper | Updated：2021-08-27

- An elderly patient with advanced lung cancer achieved long-term survival using Chinese medicine: An alternative treatment strategy for cancer patients aged 80 or older without a tissue confirmed diagnosis
- An elderly patient with advanced lung cancer achieved long-term survival using Chinese medicine: An alternative treatment strategy for cancer patients aged 80 or older without a tissue confirmed diagnosis
- 中国结合医学杂志（英文版） 2016年22卷第7期页码：545-548
- Affiliations：
  
  1. Oncology Department, Guang’anmen Hospital, China Academy of Chinese Medical Sciences,Beijing,China
  2. Beijing University of Chinese Medicine,Beijing,China
  3. Department of Japanese-Oriental (Kampo) Medicine, Graduate School of Medicine, Chiba University,Chiba,Japan
- Author bio：
- Funds：
  
  Supported by the National Natural Science Foundation of China (No. 81273718 and No. 81102719)
- DOI：10.1007/s11655-015-2309-9
  中图分类号：
- 纸质出版日期：2016，
  
  网络出版日期：2015-11-23，
Scan for full text
Liu, R., He, Sl., Hirasaki, Y. et al. An elderly patient with advanced lung cancer achieved long-term survival using Chinese medicine: An alternative treatment strategy for cancer patients aged 80 or older without a tissue confirmed diagnosis., Chin. J. Integr. Med. 22, 545–548 (2016). https://doi.org/10.1007/s11655-015-2309-9

Rui Liu, Shu-lin He, Yoshiro Hirasaki, et al. An elderly patient with advanced lung cancer achieved long-term survival using Chinese medicine: An alternative treatment strategy for cancer patients aged 80 or older without a tissue confirmed diagnosis[J]. Chinese Journal of Integrative Medicine, 2016,22(7):545-548.
Liu, R., He, Sl., Hirasaki, Y. et al. An elderly patient with advanced lung cancer achieved long-term survival using Chinese medicine: An alternative treatment strategy for cancer patients aged 80 or older without a tissue confirmed diagnosis., Chin. J. Integr. Med. 22, 545–548 (2016). https://doi.org/10.1007/s11655-015-2309-9 DOI：

Rui Liu, Shu-lin He, Yoshiro Hirasaki, et al. An elderly patient with advanced lung cancer achieved long-term survival using Chinese medicine: An alternative treatment strategy for cancer patients aged 80 or older without a tissue confirmed diagnosis[J]. Chinese Journal of Integrative Medicine, 2016,22(7):545-548. DOI： 10.1007/s11655-015-2309-9.

摘要

Abstract

关键词

lung cancerChinese Herbal MedicineAdvanced Lung CancerAstragalus membranaceusPanax Quinquefolium

Keywords

lung cancerChinese Herbal MedicineAdvanced Lung CancerAstragalus membranaceusPanax Quinquefolium

references

Chen WQ, Zhang SW, Zou XN. Evaluation on the incidence, mortality and tendency of lung cancer in China. Thoracic Cancer 2010;1:35–40.

Chen WQ, Armstrong BK, Zheng RS, Zhang SW, Yu XQ, Clements M. Cancer burden in China: a Bayesian approach. BMC Cancer 2013;13:458.

Goss PE, Strasser-Weippl K, Lee-Bychkovsky BL, Fan L, Li J, Chavarri-Guerra Y, et al. Challenges to effective cancer control in China, India, and Russia. Lancet Oncol 2014;15:489–538.

Giroh L, Yu T, Sun WJ. Chinese cancer status—challenge and opportunity. Enliven: Challenges Cancer 2014;1(1):e001.

Xu W, Towers AD, Li P, Collet JP. Traditional Chinese medicine in cancer care: perspectives and experiences of patients and professionals in China. Eur J Cancer Care (Engl) 2006;15(4):397–403.

Chen YM, Perng RP, Chen MC, Tsai CM, Ming-Liu J, Whang-Peng J. A phase I trial of vinorelbine plus gemcitabine in previously untreated inoperable (stage) non-small-cell lung cancer patients aged 80 or older. Lung Cancer 2003;40:221–226.

Kawaguchi T, Tamiya A, Tamura A, Arao M, Saito R, Matsumura A, et al. Chemotherapy is beneficial for elderly patients with advanced non-small-cell lung cancer: analysis of patients aged 70–74, 75–79, and 80 or older in Japan. Clin Lung Cancer 2012;13:442–447.

Altundag O, Stewart DJ, Fossella FV, Ayers GD, Wei W, Zhou X, et al. Many patients 80 years and older with advanced non-small cell lung cancer (NSCLC) can tolerate chemotherapy. J Thorac Oncol 2007;2:141–146.

Deng GE, Rausch SM, Jones LW, Gulati A, Kumar NB, Greenlee H, et al. Complementary therapies and integrative medicine in lung cancer. Diagnosis and management of lung cancer, 3rd ed. American College of Chest Physicians evidence-based clinical practice guidelines. Chest 2013;143:(5 Suppl):e420S–e436S.

Breen D, Barlesi F, Zemerli M, Doddoli C, Torre JP, Thomas P, et al. Results and impact of routine assessment of comorbidity in elderly patients with non-small-cell lung cancer aged > 80 years. Clin Lung Cancer 2007;8:331–334.

Ayyappan S, Gonzalez C, Yarlagadda R, Zakharia Y, Woodlock TJ. Lung cancer in the very elderly: incidence, presentation, and diagnostic decision-making. A retrospective analysis at a teaching community hospital. J Community Hosp Intern Med Perspect 2011;1:7313.

Wong R, Sagar CM, Sagar SM. Integration of Chinese medicine into supportive cancer care: a modern role for an ancient tradition. Cancer Treat Rev 2001;27:235–246.

Ruan WJ, Lai MD, Zhou JG. Anticancer effects of Chinese herbal medicine, science or myth? J Zhejiang Univ Sci B 2006;7:1006–1014.

Sun Y. The role of Chinese medicine in clinical oncology. Chin J Integr Med 2014;20:3–10.

Wang T, Xuan X, Li M, Gao P, Zheng Y, Zang W, et al. Astragalus saponins affect proliferation, invasion and apoptosis of gastric cancer BGC-823 cells. Diagn Pathol 2013;8:179.

Liu Y, Ye F, Qiu GQ, Zhang M, Wang R, He QY, et al. Effects of lactone I from Atractylodes macrocephala Koidz on cytokines and proteolysis-inducing factors in cachectic cancer patients. J First Mil Med Univ (Chin) 2005;25:1308–1311.

Cheng S, Eliaz I, Lin J, Thyagarajan-Sahu A, Sliva D. Triterpenes from Poria cocos suppress growth and invasiveness of pancreatic cancer cells through the downregulation of MMP-7. Int J Oncol 2013;42:1869–1874.

Hung JY, Yang CJ, Tsai YM, Huang HW, Huang MS. Antiproliferative activity of paeoniflorin is through cell cycle arrest and the Fas/Fas ligand-mediated apoptotic pathway in human non-small cell lung cancer A549 cells. Clin Exp Pharmacol Physiol 2008;35:141–147.

Liu LL, Chen J, Shi YP. Advances in studies on antitumor of Chinese materia medica with heat-clearingand toxinresolving functions. Chin Tradit Herbal Drug (Chin) 2012;43:1203–1210.

FULL TEXT LINK

More>

浏览量

Downloads

CSCD

文章被引用时，请邮件提醒。

Submit

工具集

关联资源

Anti-fungal test of composite agastache lotion on seven pathogenic fungi and its clinical application

Exploring the mechanism of Chinese herbal medicine in preventing and treating radiation damage of hematopoietic and immune systems

Delisheng Injection (得力生注射液), a Chinese medicinal compound, enhanced the effect of cis-platinum on lung carcinoma cell line PGCL3

Development is a high level inheritance for China Time-honored Brand products

Effect of Chinese herbal medicine for nourishing yin, supplementing qi, and activating blood on the Th1/Th2 immune balance in peripheral blood in patients with primary Sjogren’s syndrome